<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://imedic.health/en/health/news/blinatumomab-high-risk-childhood-b-cell-all-survival</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-23</news:publication_date>
      <news:title>Blinatumomab for High-Risk Childhood B-Cell ALL: What the Evidence Shows</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/fda-clinical-trial-modernization-expedited-ind-pilot</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-23</news:publication_date>
      <news:title>FDA Expedited IND Pilot: Can Rolling Review Speed First-in-Human Trials?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/winrevair-ibtrozi-fda-regulatory-updates</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-23</news:publication_date>
      <news:title>Winrevair and Ibtrozi FDA Updates: What Patients Should Know</news:title>
    </news:news>
  </url>
</urlset>
